MediWound (MDWD) EBIT Growth (5y) (2018 - 2025)

MediWound (MDWD) EBIT Growth (5y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn -
2 Nanobiotix 1,930.72 Bn 1,930.66 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 471.36 Bn 466.57 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.47 Bn 116.22 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.28 Bn 61.52 Bn 3.31 Bn
7 Belite Bio 62.00 Bn 62.00 Bn -
8 Argenx Se 56.08 Bn 50.89 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn
10 MediWound 167.52 Mn 162.72 Mn 278,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -26.73%
Sep 30, 2025 -33.44%
Jun 30, 2025 -16.13%
Mar 31, 2025 -18.82%
Dec 31, 2024 -14.18%
Sep 30, 2024 -13.30%
Jun 30, 2024 -18.35%
Mar 31, 2024 -0.85%
Dec 31, 2023 -22.31%
Sep 30, 2023 -6.19%
Jun 30, 2023 -4.05%
Mar 31, 2023 -3.28%
Dec 31, 2022 21.08%
Sep 30, 2022 -4.65%
Jun 30, 2022 0.16%
Mar 31, 2022 2.16%
Dec 31, 2021 4.82%
Sep 30, 2021 10.22%
Jun 30, 2021 15.45%
Mar 31, 2021 13.66%